FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:370-371 August 1, 2002 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Alrajhi, A. A. PubMed Citation

To the Editor: Alrajhi et al. (March 21 issue)¹ report on the efficacy of systemic fluconazole for Old World cutaneous leishmaniasis caused by Leishmania major. Although this therapy was more efficacious than placebo, the rationale for the study is questionable. Because of potential side effects and high costs, it is unlikely that any systemic therapy will ever become the first-choice therapy for uncomplicated Old World cutaneous leishmaniasis, which is a self-limited skin disease that is usually amenable to topical treatments. Moreover, the cost of six weeks of treatment with fluconazole at a dose of 200 mg per day is . . . [Full Text of this Article]

This article has been cited by other articles:

• MORIZOT, G., DELGIUDICE, P., CAUMES, E., LAFFITTE, E., MARTY, P., DUPUY, A., SARFATI, C., HADJ-RABIA, S., DARIE, H., LE GUERN, A.-S., SALAH, A. B., PRATLONG, F., DEDET, J.-P., GROGL, M., BUFFET, P. A. (2007). HEALING OF OLD WORLD CUTANEOUS LEISHMANIASIS IN TRAVELERS TREATED WITH FLUCONAZOLE: DRUG EFFECT OR SPONTANEOUS EVOLUTION?. Am J Trop Med Hyg 76: 48-52 [Abstract] [Full Text]